BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah S, Ereshefsky B, Pontiggia L, Cawley M. Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection. Hosp Pharm 2019;54:294-9. [PMID: 31555004 DOI: 10.1177/0018578718787439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Cheng YW, Fischer M. Treatment of Severe and Fulminnant Clostridioides difficile Infection. Curr Treat Options Gastroenterol 2019;17:524-33. [PMID: 31745820 DOI: 10.1007/s11938-019-00262-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Stallmach A, Katzer K, Reuken P. [Non-severe Clostridioides difficile Infection: Are the data adequate to give up metronidazole?]. Z Gastroenterol 2020;58:778-84. [PMID: 32785914 DOI: 10.1055/a-1190-5735] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]